Literature DB >> 30389825

Principal Components Analysis of Brain Metabolism Predicts Development of Alzheimer Dementia.

Ganna Blazhenets1, Yilong Ma2, Arnd Sörensen3, Gerta Rücker4, Florian Schiller3, David Eidelberg2, Lars Frings3,5, Philipp T Meyer.   

Abstract

The value of 18F-FDG PET for predicting conversion from mild cognitive impairment (MCI) to Alzheimer dementia (AD) is currently under debate. We used a principal components analysis (PCA) to identify a metabolic AD conversion-related pattern (ADCRP) and investigated the prognostic value of the resulting pattern expression score (PES).
Methods: 18F-FDG PET scans of 544 MCI patients were obtained from the Alzheimer Disease Neuroimaging Initiative database and analyzed. We implemented voxel-based PCA and standard Statistical Parametric Mapping analysis (as a reference) to disclose cerebral metabolic patterns associated with conversion from MCI to AD. By Cox proportional hazards regression, we examined the prognostic value of candidate predictors. Also, we constructed prognostic models with clinical, imaging, and clinical and imaging variables in combination.
Results: PCA revealed an ADCRP that involved regions with relative decreases in metabolism (temporoparietal, frontal, posterior cingulate, and precuneus cortices) and relative increases in metabolism (sensorimotor and occipital cortices, cerebellum, and left putamen). Among the predictor variables age, sex, Functional Activities Questionnaire, Mini-Mental State Examination, apolipoprotein E, PES, and normalized 18F-FDG uptake (regions with significant hypo- and hypermetabolism in patients with conversion vs. those without conversion), PES was the best independent predictor of conversion (hazard ratio, 1.77, per z score increase; 95% CI, 1.24-2.52; P < 0.001). Moreover, adding PES to the model including the clinical variables significantly increased its prognostic value.
Conclusion: The ADCRP expression score was a valid predictor of conversion. A combination of clinical variables and PES yielded a higher accuracy than each single tool in predicting conversion from MCI to AD, underlining the incremental utility of 18F-FDG PET.
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  18F-FDG PET; Alzheimer dementia; Cox model; PCA; mild cognitive impairment

Year:  2018        PMID: 30389825     DOI: 10.2967/jnumed.118.219097

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  14 in total

Review 1.  Resistance, vulnerability and resilience: A review of the cognitive cerebellum in aging and neurodegenerative diseases.

Authors:  Katharine J Liang; Erik S Carlson
Journal:  Neurobiol Learn Mem       Date:  2019-01-07       Impact factor: 2.877

2.  Controls-based denoising, a new approach for medical image analysis, improves prediction of conversion to Alzheimer's disease with FDG-PET.

Authors:  Dominik Blum; Inga Liepelt-Scarfone; Daniela Berg; Thomas Gasser; Christian la Fougère; Matthias Reimold
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-24       Impact factor: 9.236

3.  A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment.

Authors:  Min Wang; Zhuangzhi Yan; Shu-Yun Xiao; Chuantao Zuo; Jiehui Jiang
Journal:  Behav Neurol       Date:  2020-08-18       Impact factor: 3.342

4.  Using radiomics-based modelling to predict individual progression from mild cognitive impairment to Alzheimer's disease.

Authors:  Jiehui Jiang; Min Wang; Ian Alberts; Xiaoming Sun; Taoran Li; Axel Rominger; Chuantao Zuo; Ying Han; Kuangyu Shi; For The Alzheimer's Disease Neuroimaging Initiative
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-15       Impact factor: 10.057

5.  Validation of the Alzheimer Disease Dementia Conversion-Related Pattern as an ATN Biomarker of Neurodegeneration.

Authors:  Ganna Blazhenets; Lars Frings; Yilong Ma; Arnd Sörensen; David Eidelberg; Jens Wiltfang; Philipp T Meyer
Journal:  Neurology       Date:  2021-01-06       Impact factor: 9.910

6.  Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer's dementia.

Authors:  Min Wang; Jiehui Jiang; Zhuangzhi Yan; Ian Alberts; Jingjie Ge; Huiwei Zhang; Chuantao Zuo; Jintai Yu; Axel Rominger; Kuangyu Shi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-04-22       Impact factor: 9.236

7.  Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19.

Authors:  Jonas A Hosp; Andrea Dressing; Ganna Blazhenets; Tobias Bormann; Alexander Rau; Marius Schwabenland; Johannes Thurow; Dirk Wagner; Cornelius Waller; Wolf D Niesen; Lars Frings; Horst Urbach; Marco Prinz; Cornelius Weiller; Nils Schroeter; Philipp T Meyer
Journal:  Brain       Date:  2021-04-03       Impact factor: 13.501

8.  Principal-Component Analysis-Based Measures of PET Data Closely Reflect Neuropathologic Staging Schemes.

Authors:  Ganna Blazhenets; Lars Frings; Arnd Sörensen; Philipp T Meyer
Journal:  J Nucl Med       Date:  2020-10-23       Impact factor: 10.057

9.  Application of Data Mining Algorithms for Dementia in People with HIV/AIDS.

Authors:  Luana Ibiapina Cordeiro Calíope Pinheiro; Maria Lúcia Duarte Pereira; Marcial Porto Fernandez; Francisco Mardônio Vieira Filho; Wilson Jorge Correia Pinto de Abreu; Pedro Gabriel Calíope Dantas Pinheiro
Journal:  Comput Math Methods Med       Date:  2021-07-09       Impact factor: 2.238

10.  Predictive Value of 18F-Florbetapir and 18F-FDG PET for Conversion from Mild Cognitive Impairment to Alzheimer Dementia.

Authors:  Ganna Blazhenets; Yilong Ma; Arnd Sörensen; Florian Schiller; Gerta Rücker; David Eidelberg; Lars Frings; Philipp T Meyer
Journal:  J Nucl Med       Date:  2019-10-18       Impact factor: 11.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.